Drug
CP
CP is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_1
1
25%
Ph phase_4
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Recruiting1
Withdrawn1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed125%
recruiting125%
withdrawn125%
active_not_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruitingphase_4
Application of Autologous Stem Cells From Adipose Tissue in the Regeneration of Knee Joint Cartilage
NCT07405840
recruitingnot_applicable
Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery
NCT05660603
completednot_applicable
A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms
NCT06471023
withdrawnphase_1
Shigella Sonnei OSPC-rDT Conjugate Vaccine
NCT01399424
Clinical Trials (4)
Showing 4 of 4 trials
NCT07405840Phase 4
Application of Autologous Stem Cells From Adipose Tissue in the Regeneration of Knee Joint Cartilage
NCT05660603Not Applicable
Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery
NCT06471023Not Applicable
A Pharmacokinetic Study of Single Oral Doses of Six Different Vitamin C Product Forms
NCT01399424Phase 1
Shigella Sonnei OSPC-rDT Conjugate Vaccine
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4